Novartis

Massachusetts Initiative Looks at Payment Plans for Novartis' SMA Gene Therapy
Massachusetts Initiative Looks at Payment Plans for Novartis' SMA Gene Therapy
BioSpace
Massachusetts
Novartis
SMA
gene therapy
Kymriah
Flag link:
FDA Gives Amneal's Generic Alzheimer’s & Parkinson’s Patch a Thumbs-Up
FDA Gives Amneal's Generic Alzheimer’s & Parkinson’s Patch a Thumbs-Up
BioSpace
FDA
Amneal
generics
Novartis
Exelon Patch
Alzheimer's disease
Parkinson's Disease
Flag link:
Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical
Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical
Fierce Pharma
Allergan
Botox
migraines
CGRP blockers
Amgen
Novartis
Aimovig
Teva Pharmaceutical
Ajovy
Eli Lilly
Emgality
Flag link:
NASH Space in Focus in 2019 as Firms Look to Diversify
NASH Space in Focus in 2019 as Firms Look to Diversify
Yahoo/Zacks.com
NASH
Gilead Sciences
Merck
Roche
Novartis
Jecure Therapeutics
Pfizer
Celgene
Eli Lilly
Flag link:
NICE turns down Novartis' Aimovig, flagging clinical trial concerns
NICE turns down Novartis' Aimovig, flagging clinical trial concerns
Biopharma Dive
NICE
UK
Amgen
Novartis
migraines
Aimovig
Flag link:
JPM recap: Must-reads of the week, from FDA to IPO to M&A and more
JPM recap: Must-reads of the week, from FDA to IPO to M&A and more
Fierce Pharma
JPMHC 2019
Merck
FDA
M&A
Celgene
Bristol-Myers Squibb
Genevant
IPOs
Eli Lilly
Novartis
GSK
Teva Pharmaceutical
Alexion
Pear Therapeutics
Flag link:
Novartis Defends Itself Against Kickback Allegations from Former Employee
Novartis Defends Itself Against Kickback Allegations from Former Employee
BioSpace
Novartis
kickbacks
whistleblower lawsuits
breast cancer
Flag link:
Novartis puts AI on the job to help reps say the right things to the right doctors
Novartis puts AI on the job to help reps say the right things to the right doctors
Fierce Pharma
Novartis
digital technology
drug reps
artificial intelligence
Flag link:
Day One of JPM Brings Excitement and Promise for a New Year in Biotech and Pharma
Day One of JPM Brings Excitement and Promise for a New Year in Biotech and Pharma
BioSpace
JPMHC 2019
M&A
Eli Lilly
Loxo Oncology
SAGE Therapeutics
Sanofi
Regeneron
Bristol-Myers Squibb
Celgene
Novartis
Gilead Sciences
Flag link:
In R&D rethink, Novartis ditches part of $2.6B Xencor bispecific pact
In R&D rethink, Novartis ditches part of $2.6B Xencor bispecific pact
Fierce Biotech
Novartis
Xencor
bispecific antibodies
Flag link:
Novartis building out cell and gene therapy platform that'll lead the pack, CEO promises
Novartis building out cell and gene therapy platform that'll lead the pack, CEO promises
Fierce Pharma
Novartis
Pharma CEOs
CAR-T
Kymriah
Vas Narasimhan
JPMHC 2019
Flag link:
Novartis shares data on discontinued antibiotic research
Novartis shares data on discontinued antibiotic research
BioCentury
Novartis
R&D
antibiotics
Flag link:
For CAR-T Cancer Fighters in the Real World, Two Roads Diverge
For CAR-T Cancer Fighters in the Real World, Two Roads Diverge
Xconomy
cancer
CAR-T
Gilead Sciences
Yescarta
Novartis
Kymriah
Flag link:
Why did Liz Barrett turn her back on a top job at Novartis in exchange for the helm of a biotech you never heard of?
Why did Liz Barrett turn her back on a top job at Novartis in exchange for the helm of a biotech you never heard of?
Endpoints
Liz Barrett
Novartis
Urogen
Flag link:
Novartis (NVS) Benefits From New Drugs & Key Acquisitions
Novartis (NVS) Benefits From New Drugs & Key Acquisitions
Yahoo/Zacks.com
Novartis
M&A
Flag link:
New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases
New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases
BioSpace
breast cancer
lung cancer
AstraZeneca
Tagrisso
Novartis
Gleevec
Tasigna
Bristol-Myers Squibb
Sprycel
Pfizer
Bosulif
Takeda
Iclusig
Flag link:
Big Pharma returning to U.S. price hikes in January after pause
Big Pharma returning to U.S. price hikes in January after pause
Reuters
drug pricing
Novartis
Bayer
Donald Trump
Flag link:
ICER says gene therapy may be more cost effective for spinal muscular atrophy
ICER says gene therapy may be more cost effective for spinal muscular atrophy
Yahoo/Reuters
Biogen
Spinraza
Novartis
spinal muscular atrophy
ICER
Flag link:
Novartis seeks to acquire French CAR-T contract manufacturer
Novartis seeks to acquire French CAR-T contract manufacturer
Biopharma Dive
Novartis
M&A
France
CellforCure
CMO
Kymriah
CAR-T
Flag link:
Novartis unit Alcon picks up Tear Film Innovations
Novartis unit Alcon picks up Tear Film Innovations
Mass Device
Novartis
Alcon
M&A
eye health
Tear Film Innovations
devices
Flag link:

Pages